TY - JOUR
KW - Adult
KW - Analgesics, Opioid/therapeutic use
KW - Australia/epidemiology
KW - Buprenorphine/adverse effects/therapeutic use
KW - Case-Control Studies
KW - Constipation/chemically induced/epidemiology
KW - Depression
KW - Drug-Related Side Effects and Adverse Reactions/epidemiology
KW - Female
KW - Humans
KW - Male
KW - Methadone/adverse effects/therapeutic use
KW - Opiate Substitution Treatment/adverse effects
KW - Opioid-Related Disorders/drug therapy
KW - Prevalence
KW - Sex Factors
KW - Young Adult
KW - buprenorphine
KW - Cardiac
KW - Gender
KW - Methadone
KW - PAC-SYM
KW - Sex
KW - Somatic
KW - Symptoms
AU - Paul S. Haber
AU - Mahmoud Elsayed
AU - David Espinoza
AU - Nicholas Lintzeris
AU - Anne-Sophie Veillard
AU - Richard Hallinan
A1 - 
AD - Drug Health Services, Sydney Local Heath District, Australia; Sydney Medical School, Camperdown, 2006 NSW, Australia. Electronic address: Paul.haber@sydney.edu.au.; Liverpool Hospital, South Western Sydney Local Heath District, Liverpool, 2170 NSW, Australia.; NHMRC Clinical Trials Centre, The University of Sydney, Australia.; Sydney Medical School, Camperdown, 2006 NSW, Australia; The Langton Centre, South Eastern Sydney Local Health District, Australia.; NHMRC Clinical Trials Centre, The University of Sydney, Australia.; Sydney Medical School, Camperdown, 2006 NSW, Australia; The Byrne Surgery, Redfern, NSW, Australia.
BT - Drug and alcohol dependence
C5 - Measures; Medically Unexplained Symptoms; Opioids & Substance Use
CY - Ireland
DO - 10.1016/j.drugalcdep.2017.09.024
JF - Drug and alcohol dependence
LA - eng
M1 - Journal Article
PB - Elsevier B.V
PP - Ireland
PY - 2017
SN - 1879-0046; 0376-8716
SP - 132
EP - 139
EP - 
T1 - Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment
T2 - Drug and alcohol dependence
TI - Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment
U1 - Measures; Medically Unexplained Symptoms; Opioids & Substance Use
U2 - 29054032
U3 - 10.1016/j.drugalcdep.2017.09.024
VL - 181
VO - 1879-0046; 0376-8716
Y1 - 2017
Y2 - Dec 1
ER -